# Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies

> **NCT02566395** · PHASE3 · COMPLETED · sponsor: **Northwell Health** · enrollment: 10 (estimated)

## Conditions studied

- Acute Lymphoblastic Leukemia
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Chronic Myelogenous Leukemia
- Non-Hodgkin Lymphoma
- Hodgkin Lymphoma

## Interventions

- **RADIATION:** Radiation
- **DRUG:** Cyclophosphamide
- **BIOLOGICAL:** Donor Lymphocyte Infusion (DLI)
- **BIOLOGICAL:** Haploidentical Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT02566395
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2022-01-14
- **Final completion:** 2022-02-14
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2022-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02566395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02566395, "Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02566395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*